DIANA CHOU: Open Payments
NPI 1164820940 · KATY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,006 in 201 payments from 20 companies in 2025. Trend: 2023 $2,936 · 2024 $3,724 · 2025 $4,006
Food & beverage: $3,717Education: $289
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 25 | $483 |
| ABBVIE INC. | 23 | $470 |
| Novartis Pharmaceuticals Corporation | 22 | $416 |
| GENZYME CORPORATION | 9 | $400 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $284 |
| UCB, Inc. | 8 | $282 |
| PFIZER INC. | 16 | $245 |
| Galderma Laboratories, L.P. | 17 | $245 |
| Organon LLC | 16 | $228 |
| LEO Pharma Inc. | 15 | $188 |
Products named: TREMFYA, DUPIXENT, COSENTYX, SKYRIZI, Bimzelx, CIBINQO, RINVOQ, NEMLUVIO.
Industry payments across TX — which companies pay providers there.
